Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease.
about
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular diseaseEffect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysisBenazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression.
P2860
Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of spironolactone combi ...... on chronic glomerular disease.
@en
type
label
Effect of spironolactone combi ...... on chronic glomerular disease.
@en
prefLabel
Effect of spironolactone combi ...... on chronic glomerular disease.
@en
P2093
P2860
P356
P1476
Effect of spironolactone combi ...... on chronic glomerular disease.
@en
P2093
Junjie Gao
Weisong Wang
Yinghao Sun
Zhonghai Zhou
P2860
P304
P356
10.3892/ETM.2013.1335
P577
2013-10-09T00:00:00Z